|
PR01 – 11.01.31: The 2011 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to Stefan Jentsch
(»Add to Infobox)
|
|
The 2011 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the German biologist STEFAN JENTSCH, a Director at the Max-Planck Institute of Biochemistry in Martinsried, and to the Norwegian neurobiologists EDVARD and MAY-BRITT MOSER, Director and Co-director respectively of the Kavli Institute for Systems Neuroscience at the Norwegian University of Science and Technology (NTNU) in Trondheim.
|
|
|
|
The LOUIS-JEANTET FOUNDATION grants the sum of CHF 700'000 for each of the 2011 prizes.
Stefan Jentsch is awarded one of the 2011 Louis-Jeantet Prizes for Medicine for his work on small protein modifiers and their role in DNA repair. Stefan Jentsch pioneered studies on protein modifications by ubiquitin and related proteins. Modification of proteins by ubiquitin usually targets the proteins for degradation. However, Stefan Jentsch’s research revealed that ubiquitin plays also a crucial role in genome maintenance and DNA repair. This research has significant medical importance as damaged DNA can cause various diseases, notably cancer.
The key research fields encouraged by the Louis-Jeantet Prize for Medicine are physiology, biophysics, structural biology, biochemistry, cellular and molecular biology, developmental biology and genetics. As one of the best-endowed awards in Europe, the Louis-Jeantet Prize for Medicine fosters scientific excellence. It is not intended as the consecration for work that has been completed, but to encourage the continuation of innovative research projects with high added value and of more or less immediate practical significance in the treatment of diseases.
For further information please download the PDF file and visit the links:
FOUNDATION LOUIS-JEANTET
Max Planck Institute of Biochemistry
|
| MEMBERS (1/1) |
|
| DOWNLOADS (1/1) |
|
2011 LOUIS-JEANTET PRIZE FOR MEDICINE
|
|
|
|
Home
